Benefits from unearthing "a biochemical rosetta stone"

Journal of Biological Chemistry

Volumn 285, Issue 53, 2010, Pages 41216-41221

  Brady, Roscoe O ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETOACETIC ACID; ACETONE; ACETYL COENZYME A; ALPHA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE; BICARBONATE; CERAMIDE TRIHEXOSIDE; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID; LONG CHAIN FATTY ACID; MALONYL COENZYME A; PALMITOYL COENZYME A; PLACENTA ENZYME; PYRIDOXAL 5 PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SHORT CHAIN FATTY ACID; SIALIDASE; SPHINGOSINE; URIDINE DIPHOSPHATE GALACTOSE;

ACETYLATION; ARTICLE; BRAIN MICROSOME; CATALYSIS; CHEMICAL ANALYSIS; CHEMICAL REACTION; CHOLESTEROL METABOLISM; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME DEGRADATION; ENZYME PURIFICATION; ENZYME REPLACEMENT; ENZYME STRUCTURE; ENZYME SYNTHESIS; FABRY DISEASE; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; GAUCHER DISEASE; HUMAN; INCUBATION TIME; LYSOSOME STORAGE DISEASE; MACROPHAGE; NIEMANN PICK DISEASE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL;

ANIMALS; BIOCHEMISTRY; FEMALE; GLUCOSYLCERAMIDASE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALE; SPHINGOLIPIDOSES; UNITED STATES;

EID: 78650658178     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.X110.197954     Document Type: Article

References (46)

1. Brady, R. O., and Gurin, S. (1951) The synthesis of radioactive cholesterol and fatty acids in vitro. J. Biol. Chem. 189, 371-377
2. Brady, R. O., and Gurin, S. (1950) The biosynthesis of radioactive fatty acids and cholesterol. J. Biol. Chem. 186, 461-469
3. Brady, R. O., and Gurin, S. (1950) The biosynthesis of labeled fatty acids and cholesterol in experimental diabetes. J. Biol. Chem. 187, 589-596
4. Brady, R. O., Lukens, F. D. W., and Gurin, S. (1951) Synthesis of radioactive fatty acids in vitro and its hormonal control. J. Biol. Chem. 193, 459-464
5. Brady, R. O., and Gurin, S. (1951) The biosynthesis of radioactive long chain fatty acids by homogenized pigeon liver tissue. Arch. Biochem. Biophys. 34, 221-222
6. Brady, R. O., and Gurin, S. (1952) The biosynthesis of fatty acids by cell-free or water-soluble enzyme systems. J. Biol. Chem. 199, 421-431
7. Brady, R. O., and Gurin, S. (1952) The biosynthesis of fatty acids in cell-free systems. Brookhaven Symp. Biol. 5, 162-175
8. Brady, R. O., Walser, J., and Agranoff, B. W. (1953) Elaboration of steroid hormones by surviving adrenal tissue slices obtained from thermally stressed dogs. Proc. Soc. Exp. Biol. Med. 84, 634-636
9. 2. J. Biol. Chem. 211, 773-779
10. Brady, R. O., and Stadtman, E. R. (1954) Enzymatic thioltransacetylation. J. Biol. Chem. 211, 621-629
11. Brady, R. O. (1958) The enzymatic synthesis of fatty acids by aldol condensation. Proc. Natl. Acad. Sci. U.S.A. 44, 993-998
12. Brady, R. O. (1960) Biosynthesis of fatty acids. II. Studies with enzymes obtained from brain. J. Biol. Chem. 235, 3099-3103
13. Thudicum, J. L. W. (1884) A Treatise on the Chemical Composition of Brain, Baillière, Tindall & Cox, London
14. Brady, R. O., and Koval, G. J. (1957) Biosynthesis of sphingosine in vitro. J. Am. Chem. Soc. 79, 2648-2649
15. Buton, R. M., Sodd, M. A., and Brady, R. O. (1958) The incorporation of galactose into galactolipids. J. Biol. Chem. 233, 1053-1060
16. Lieb, H. (1924) Cerebrosidespeicherung bei Splenomegalie Typus Gaucher. Ztschr. Physiol. Chem. 140, 305-313
17. Aghion, A. (1934) La Maladie de gaucher dans l'Enfance. Ph.D dissertation, University of Paris, Paris
18. Thannhauser, S. J. (1950) in Lipidoses: Diseases of Cellular Lipid Metabolism (Christian, H. A., ed) Oxford University Press, New York
19. Trams, E. G., and Brady, R. O. (1960) Cerebroside synthesis in Gaucher's disease. J. Clin. Invest. 39, 1546-1550
20. Shapiro, D., and Flowers, H. M. (1962) Studies on sphingolipids. VII. Synthesis and configuration of natural sphingomyelins. J. Am. Chem. Soc. 84, 1047-1050
21. Brady, R. O., Kanfer, J., and Shapiro, D. (1965) The metabolism of glucocerebrosides. I. Purification and properties of a glucocerebroside-cleaving enzyme from spleen tissue. J. Biol. Chem. 240, 39-42
22. Brady, R. O., Kanfer, J. N., and Shapiro, D. (1965) Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease. Biochem. Biophys. Res. Commun. 18, 221-225
23. Brady, R. O., Kanfer, J. N., Bradley, R. M., and Shapiro, D. (1966) Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J. Clin. Invest. 45, 1112-1115
24. Weinreb, N. J., Brady, R. O., and Tappel, A. L. (1968) The lysosomal localization of sphingolipid hydrolases. Biochim. Biophys. Acta 159, 141-146
25. Brady, R. O. (Feb. 22, 1971) The Chemical Innovators: unearthing a biochemical Rosetta Stone. Chemical & Engineering News
26. Brady, R. O., Kanfer, J. N., Mock, M. B., and Fredrickson, D. S. (1966) The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann- Pick disease. Proc. Natl. Acad. Sci. U.S.A. 55, 366-369
27. Brady, R. O., Gal, A. E., Bradley, R. M., Martensson, E., Warshaw, A. L., and Laster, L. (1967) Enzymatic defect in Fabry's disease: Ceramidetrihexosidase deficiency. N. Engl. J. Med. 276, 1163-1167
28. Kolodny, E. H., Brady, R. O., and Volk, B. W. (1969) Demonstration of an alteration of ganglioside metabolism in Tay-Sachs disease. Biochem. Biophys. Res. Commun. 37, 526-531
29. Tallman, J. F., Johnson, W. G., and Brady, R. O. (1972) The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue. J. Clin. Invest. 51, 2339-2345
30. Kampine, J. P., Brady, R. O., Kanfer, J. N., Feld, M., and Shapiro, D. (1967) The diagnosis of Gaucher's disease and Niemann-Pick disease using small samples of venous blood. Science 155, 86-88
31. Ho, M. W., Seck, J., Schmidt, D., Veath, M. L., Johnson, W. G., Brady, R. O., and O'Brien, J. S. (1972) Adult Gaucher's disease: kindred studies and demonstration of a deficiency of acid β-glucosidase in cultured fibroblasts. Am. J. Hum. Genet. 24, 37-45
32. Brady, R. O., Johnson, W. G., and Uhlendorf, B. W. (1971) Identification of heterozygous carriers of lipid storage diseases. Am. J. Med. 51, 423-431
33. Brady, R. O., Uhlendorf, B. W., and Jacobson, C. B. (1971) Fabry's disease: antenatal detection. Science 172, 174-175
34. Epstein, C. J., Brady, R. O., Schneider, E. L., Bradley, R. M., and Shapiro, D. (1971) In utero diagnosis of Niemann-Pick disease. Am. J. Hum. Genet. 23, 533-535
35. Schneider, E. L., Ellis, W. G., Brady, R. O., McCulloch, J. R., and Epstein, C. J. (1972) Infantile (type II) Gaucher's disease: in utero diagnosis and fetal pathology. J. Pediatr. 81, 1134-1139
36. Brady, R. O. (1966) Sphingolipidoses. N. Engl. J. Med. 275, 312-318
37. Johnson, W. G., and Brady, R. O. (1972) Ceramidetrihexosidase from human placenta. Methods Enzymol. XXVIII, 849-856
38. Brady, R. O., Tallman, J. F., Johnson, W. G., Gal, A. E., Leahy, W. E., Quirk, J. M., and Dekaban, A. S. (1973) Replacement therapy for inherited enzyme deficiency: use of purified ceramidetrihexosidase in Fabry's disease. N. Engl. J. Med. 289, 9-14
39. Pentchev, P. G., Brady, R. O., Hibbert, S. R., Gal, A. E., and Shapiro, D. (1973) Isolation and characterization of glucocerebrosidase from human placental tissue. J. Biol. Chem. 248, 5256-5261
40. Brady, R. O., Pentchev, P. G., Gal, A. E., Hibbert, S. R., and Dekaban, A. S. (1974) Replacement therapy for inherited enzyme deficiency: use of purified glucocerebrosidase in Gaucher's disease. N. Engl. J. Med. 291, 989-993
41. Pentchev, P. G., Brady, R. O., Gal, A. E., and Hibbert, S. R. (1975) Replacement therapy for inherited enzyme deficiency: sustained clearance of accumulated glucocerebroside in Gaucher's disease following infusion of purified glucocerebrosidase. J. Mol. Med. 1, 73-78
42. Furbish, F. S., Blair, H. E., Shiloach, J., Pentchev, P. G., and Brady, R. O. (1977) Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration. Proc. Natl. Acad. Sci. U.S.A. 74, 3560-3563
43. Brady, R. O., and Furbish, F. S. (1982) Enzyme replacement therapy: specific targeting of exogenous enzymes to storage cells. In: Membranes and Transport (Martonosi, A. N., ed) Vol. 2, pp. 587-592, Plenum Publishing Corp., New York
44. Barton, N. W., Furbish, F. S., Murray, G. J., Garfield, M., and Brady, R. O. (1990) Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher's disease. Proc. Natl. Acad. Sci. U.S.A. 87, 1913-1916
45. Barton, N. W., Brady, R. O., Dambrosia, J. M., DiBisceglie, A. M., Doppelt, S. H., Hill, S. C., Mankin, H. J., Murray, G. J., Parker, R. I., Argoff, C. E., Grewal, R. P., and Yu, K.-T. (1991) Replacement therapy for inherited enzyme deficiency: macrophage-targeted glucocerebrosidase for Gaucher's disease. N. Engl. J. Med. 324, 1464-1470
46. Grabowski, G. A., Barton, N. W., Pastores, G., Dambrosia, J. M., Banerjee, T. K., McKee, M. A., Parker, C., Schiffmann, R., Hill, S. C., and Brady, R. O. (1995) Enzyme therapy in Gaucher's disease type 1: comparative efficacy of mannoseterminated glucocerebrosidase from natural and recombinant sources. Ann. Int. Med. 122, 33-39